Shopping Cart
Remove All
Your shopping cart is currently empty
Lusvertikimab
😃Good
Catalog No. T76893Cas No. 2375835-91-7
Alias S-95011, S95011, OSE-127, OSE127
Lusvertikimab (OSE-127) is a humanized anti-IL7R antibody with anti-leukemic efficacy that reduces leukemic load in xenograft ALL through antibody-dependent phagocytosis and may be used to study leukemia.
Lusvertikimab
Lusvertikimab
😃Good
Purity: 95%
Catalog No. T76893Alias S-95011, S95011, OSE-127, OSE127Cas No. 2375835-91-7
Lusvertikimab (OSE-127) is a humanized anti-IL7R antibody with anti-leukemic efficacy that reduces leukemic load in xenograft ALL through antibody-dependent phagocytosis and may be used to study leukemia.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | In Stock | In Stock | |
| 5 mg | $562 | In Stock | In Stock | |
| 10 mg | $868 | - | In Stock | |
| 25 mg | $1,280 | - | In Stock | |
| 50 mg | $1,730 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:98.4% (SDS-PAGE); 99% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Lusvertikimab (OSE-127) is a humanized anti-IL7R antibody with anti-leukemic efficacy that reduces leukemic load in xenograft ALL through antibody-dependent phagocytosis and may be used to study leukemia. |
| In vitro | Lusvertikimab inhibits STAT5 phosphorylation in IL7-dependent ALL cell lines and patient-derived xenograft (PDX) samples. [2] |
| In vivo | Lusvertikimab-treated mice exhibited a reduction in peripheral hemoblasts in 95% of the xenograft (PDX) samples when control mice showed overt clinical signs of leukemia. [1] |
| Synonyms | S-95011, S95011, OSE-127, OSE127 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-7Ra/CD127 |
| Molecular Weight | 145.63 kDa |
| Cas No. | 2375835-91-7 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Lusvertikimab | purchase Lusvertikimab | Lusvertikimab cost | order Lusvertikimab | Lusvertikimab in vivo | Lusvertikimab in vitro | Lusvertikimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.